Discuss This Drug

labivudine and zidovudine

CHEBI:CHEBI_756300

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
dosage_form
TABLET, FILM COATED
active_ingredient_strength
300 mg/1
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
marketing_start_date
20130201
package_marketing_start_date
01-FEB-13
active_ingredient_name
ZIDOVUDINE
labeler_name
Glaxo Operations UK Ltd
generic_name
labivudine and zidovudine
product_ndc
63379-086
spl_id
a90775a3-0d42-4e5a-b574-63bd017db54b
package_ndc
63379-086-00
package_description
18521 TABLET, FILM COATED in 1 DRUM (63379-086-00)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class